Alibaba Health Declares Final Dividend for FY2026

Alibaba Health Information Technology ( (HK:0241) ) has issued an announcement.

Alibaba Health Information Technology has declared a final ordinary cash dividend of RMB 0.0595 per share for the financial year ended 31 March 2026, with the Hong Kong dollar equivalent and exchange rate to be announced. The dividend is subject to shareholder approval on 7 August 2026, with the shares trading ex-dividend on 12 August, a record date of 13 August, and payment scheduled for 2 September 2026, signaling a return of cash to investors and underscoring the company’s commitment to shareholder returns.

The company has appointed Tricor Investor Services Limited in Hong Kong as its share registrar to handle entitlement and registration matters related to this distribution. No special withholding tax arrangements, warrants, or convertible securities are associated with this dividend, and the announcement also confirms the current composition of the board, providing governance transparency alongside the payout details.

The most recent analyst rating on (HK:0241) stock is a Sell with a HK$4.60 price target. To see the full list of analyst forecasts on Alibaba Health Information Technology stock, see the HK:0241 Stock Forecast page.

More about Alibaba Health Information Technology

Alibaba Health Information Technology Limited is a Hong Kong-listed healthcare technology company operating in the broader health services and medical e-commerce space. It focuses on providing technology-enabled healthcare solutions and related services to consumers and medical stakeholders in mainland China and other relevant markets.

Average Trading Volume: 85,020,990

Technical Sentiment Signal: Strong Sell

Current Market Cap: HK$72.76B

See more data about 0241 stock on TipRanks’ Stock Analysis page.